Abstract
Objective This work aims to determine the AVEM duration and number of captured seizures required to resolve different clinical questions, using a retrospective review of ictal recordings.
Methods Patients who underwent home-based AVEM had event data analyzed retrospectively. Studies were grouped by clinical indication: seizure differential diagnosis, classification, or treatment assessment. The proportion of studies where the conclusion was changed after the first seizure was determined, as was the AVEM duration needed for at least 99% of studies to reach a diagnostic conclusion.
Results The referring clinical question was not answered entirely by the first event in 29.56% (n=227) of studies. Diagnostic and classification indications required a minimum of 7 days for at least 99% of studies to be answered, whilst treatment-assessment required at least 6 days.
Conclusions At least 7 days of monitoring, and potentially multiple events, are required to adequately answer these clinical questions in at least 99% of patients. The widely applied 72 hours or single event recording cut-offs may be insufficient to correctly answer these three indications in a substantial proportion of patients.
Significance Extended duration of monitoring and capturing multiple events should be considered when attempting to capture seizures on AVEM.
Competing Interest Statement
MJC, DRF, and ESN declare a financial interest in Seer Medical Pty. Ltd. The other authors declare no competing interests.
Funding Statement
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approval for this study was granted by St Vincents Hospital Melbourne Human Research Ethics Committee
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Contact Prof. Mark Cook, markcook{at}unimelb.edu.au, Phone: 03 9288 3340, Fax: (03) 9288 3091, Address: 404, Clinical Sciences Block, St Vincent’s Hospital Melbourne, 41 Victoria Parade, Fitzroy VIC 3065, Australia
Data Availability
All data produced in the present study are available upon reasonable request to the authors
